Literature DB >> 32358705

Neurological manifestations of neurofibromatosis: a review.

Michael Bayat1, Allan Bayat2.   

Abstract

Neurofibromatosis type 1(NF1) is a dominantly inherited genetic disorder caused by a mutation in the NF1 tumor-suppressor gene. Patients are prone to develop benign and malignant tumors not only in the central and peripheral nervous system but also in other parts of the body. Apart from tumors, neurofibromatosis may also be associated with neurological symptoms and disorders such as cerebrovascular disease, epilepsy, neuropathy, and headache. This article seeks to review the different neurological manifestations of neurofibromatosis.

Entities:  

Keywords:  Cerebrovascular disorders; Epilepsy; Headache; Neoplasms; Neurofibromatosis; Neuropathy

Mesh:

Year:  2020        PMID: 32358705     DOI: 10.1007/s10072-020-04400-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

1.  Type-1 neurofibromatosis mimicking multiple mononeuropathy: the help of nerve ultrasound.

Authors:  Daniele Orsucci; Gianluca Moscato; Vincenzo Ricci; Stefano Galletti; Marco Vista
Journal:  Neurol Sci       Date:  2021-03-01       Impact factor: 3.307

Review 2.  Neurofibromatosis: New Clinical Challenges in the Era of COVID-19.

Authors:  Alessio Ardizzone; Anna Paola Capra; Michela Campolo; Alessia Filippone; Emanuela Esposito; Silvana Briuglia
Journal:  Biomedicines       Date:  2022-04-19

3.  Evaluation of clinical findings and neurofibromatosis type 1 bright objects on brain magnetic resonance images of 60 Turkish patients with NF1 gene variants.

Authors:  Filiz Hazan; Semra Gürsoy; Aycan Unalp; Unsal Yılmaz; Bengü Demirağ; Sultan Aydin Köker; Berk Ozyılmaz; Kadri Murat Erdogan; Önder Kalenderer; Serkan Erkuş; Müge Gürçınar; Ajlan Tükün
Journal:  Neurol Sci       Date:  2021-01-14       Impact factor: 3.830

4.  Epilepsy in NF1: Epidemiologic, Genetic, and Clinical Features. A Monocentric Retrospective Study in a Cohort of 784 Patients.

Authors:  Ugo Sorrentino; Silvia Bellonzi; Chiara Mozzato; Valeria Brasson; Irene Toldo; Raffaele Parrozzani; Maurizio Clementi; Matteo Cassina; Eva Trevisson
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.